Wang Jie Jiang
Overview
Explore the profile of Wang Jie Jiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen R, Liu S, Kan X, Wang Y, Wang J, Wang T, et al.
Adv Sci (Weinh)
. 2024 Aug;
11(38):e2402329.
PMID: 39120980
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer and its prognosis remains poor. Although growing numbers of studies have verified the involvement of circular RNAs (circRNAs) in...
2.
Kong X, Yang X, Jiang W, Zhu D, Kong L
J Hepatocell Carcinoma
. 2023 Jul;
10:1085-1103.
PMID: 37483310
Purpose: Hepatocellular carcinoma(HCC) is the most common type of liver cancer and the sixth largest common cancer worldwide. Although surgical resection, hepatic arterial chemoembolization, targeted drugs and immunotherapy are currently...
3.
Jiao C, Feng Q, Li C, Wang D, Han S, Zhang Y, et al.
Cell Death Dis
. 2021 Jan;
12(1):63.
PMID: 33431813
Currently, the controversy regarding the expression profile and function of BUB1B in different malignancies still exist. In this project, we aimed to explore the role and molecular mechanism of BUB1B...
4.
Zhang J, Wang X, Li G, Wang D, Han S, Zhang Y, et al.
J Cancer
. 2020 Apr;
11(12):3604-3614.
PMID: 32284757
: MicroRNAs (miRNAs) play important roles in the occurrence and development of cancers. In this project, we aimed to explore the role and molecular mechanism of mir-30a-5p in cholangiocarcinoma (CCA)....
5.
Li C, Wang H, Jiang W, Li G, Zhang Y, Luo C, et al.
Oxid Med Cell Longev
. 2020 Mar;
2020:3076131.
PMID: 32190170
Objectives: Our previous study showed that aldose reductase (AR) played key roles in fatty liver ischemia-reperfusion (IR) injury by regulating inflammatory response and energy metabolism. Here, we aim to investigate...